ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 64 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $134,051 | +33.5% | 89,367 | +41.5% | 0.00% | – |
| Q2 2023 | $100,409 | +50.3% | 63,150 | -32.2% | 0.00% | – |
| Q1 2023 | $66,826 | +3561.7% | 93,150 | +2857.1% | 0.00% | – |
| Q4 2022 | $1,825 | -8.8% | 3,150 | +57.5% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 2,000 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -25.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | -50.0% | 2,000 | -16.7% | 0.00% | – |
| Q2 2021 | $8,000 | -66.7% | 2,400 | 0.0% | 0.00% | – |
| Q1 2021 | $24,000 | -7.7% | 2,400 | 0.0% | 0.00% | – |
| Q4 2020 | $26,000 | +4.0% | 2,400 | 0.0% | 0.00% | – |
| Q3 2020 | $25,000 | -50.0% | 2,400 | 0.0% | 0.00% | – |
| Q2 2020 | $50,000 | +108.3% | 2,400 | 0.0% | 0.00% | – |
| Q1 2020 | $24,000 | – | 2,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,043,212 | $46,578,000 | 47.83% |
| Soleus Capital Management, L.P. | 342,800 | $3,949,000 | 3.81% |
| ACUTA CAPITAL PARTNERS, LLC | 1,322,500 | $15,235,000 | 3.77% |
| RTW INVESTMENTS, LP | 6,386,607 | $73,574,000 | 2.78% |
| Ghost Tree Capital, LLC | 1,175,000 | $13,536,000 | 2.58% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $5,530,000 | 2.48% |
| VHCP Management III, LLC | 946,234 | $10,901,000 | 2.16% |
| Avoro Capital Advisors LLC | 5,250,000 | $60,480,000 | 1.78% |
| VHCP Management II, LLC | 383,620 | $4,419,000 | 1.16% |
| Rhenman & Partners Asset Management AB | 650,000 | $7,488,000 | 0.82% |